The Venture Codex Logo

The Venture Codex

Medicxi

25 Great Pulteney Street, London, England, W1F 9LT, United Kingdom

Overview

Investment firm specializing in life sciences and therapeutics development.

Founded

2016

Deals ยท 12mo

4

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

China
Switzerland
The Netherlands
United Kingdom
...

Sector focus

Biopharma
Biotechnology
Life Science
Venture Capital

Investment portfolio

39rounds
NAMEDATESIZE
Vaderis Therapeutics
Aug 2026Participated
$152 MSeries B
Fore Biotherapeutics
Jul 2026Led
$67 MSeries D
Altesa
Feb 2026Participated
$75 MSeries B
D3 Bio
Dec 2025Participated
$108 MSeries B
Fore Biotherapeutics
May 2025Participated
$38 MSeries D
Curevo
Mar 2025Led
$110 MSeries B
Ottimo Pharma
Dec 2024Participated
$140 MSeries A
Vicebio
Sep 2024Participated
$100 MSeries B
D3 Bio
Apr 2024Led
$62 MSeries A
ProfoundBio
Feb 2024Participated
$112 MSeries B
Alys Pharmaceuticals
Feb 2024Led
$100 MOther Equity
Fore Biotherapeutics
Aug 2023Led
$75 MSeries D
Vaderis Therapeutics
Aug 2026Participated
$152 MSeries B
Fore Biotherapeutics
Jul 2026Led
$67 MSeries D
Altesa
Feb 2026Participated
$75 MSeries B
D3 Bio
Dec 2025Participated
$108 MSeries B
Fore Biotherapeutics
May 2025Participated
$38 MSeries D
Curevo
Mar 2025Led
$110 MSeries B
Ottimo Pharma
Dec 2024Participated
$140 MSeries A
Vicebio
Sep 2024Participated
$100 MSeries B
D3 Bio
Apr 2024Led
$62 MSeries A
ProfoundBio
Feb 2024Participated
$112 MSeries B
Alys Pharmaceuticals
Feb 2024Led
$100 MOther Equity
Fore Biotherapeutics
Aug 2023Led
$75 MSeries D
39
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Medicxi: 39 funding rounds are recorded in the selected participation categories.All available history.
Medicxi: 39 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A131
Series B39
Series C+35
Other Equity23

Monthly Deal Activity

Medicxi: 39 deals are recorded across 128 months.All available history.
Medicxi: 39 deals are recorded across 128 months. All available history
MonthDeals
Mar '162
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '172
Mar '170
Apr '170
May '171
Jun '170
Jul '171
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '181
May '181
Jun '181
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '191
May '191
Jun '190
Jul '190
Aug '190
Sep '191
Oct '190
Nov '190
Dec '190
Jan '201
Feb '200
Mar '201
Apr '200
May '201
Jun '201
Jul '200
Aug '200
Sep '201
Oct '201
Nov '201
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '211
Jul '211
Aug '212
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '241
Jan '250
Feb '250
Mar '251
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '261
Sep '260
Oct '260

Sector Breakdown

Medicxi: Health & Life Sciences is the largest displayed sector by deal count (39 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Medicxi: Health & Life Sciences is the largest displayed sector by deal count (39 deals). All available history
SectorDeals
Health & Life Sciences39
Enterprise Software1
Manufacturing1
Media & Entertainment1

Deal Size Distribution

Medicxi: 39 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Medicxi: 39 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M2
$10M-$25M9
$25M-$50M8
$50M-$100M10
$100M-$250M10
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Medicxi: United States has the largest recorded deal count among the displayed regions (23 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Medicxi: United States has the largest recorded deal count among the displayed regions (23 deals). All available history
RegionDeals
United States23
Europe14
China2
Medicxi: 20 co-investors are shown, with RA Capital Management sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Medicxi: 20 co-investors are shown, with RA Capital Management sharing 9 recorded deals. All available history
Co-investorShared deals
RA Capital Management9
OrbiMed8
Longitude Capital6
Janus Henderson Investors5
Advent Life Sciences4
HBM Healthcare Investments4
SR One4
Abingworth3
Frazier Healthcare Partners3
Novartis3
Osage University Partners3
Roche Venture3
Samsara BioCapital3
Wellington Management3
3B Future Health Fund2
Arix Bioscience2
Cambridge Enterprise2
Chiesi Ventures2
Columbus Venture Partners2
Cormorant Asset Management2

Investment Strategy

Medicxi: Led accounts for 54% and participating for 46% of round participation.All available history.
Medicxi: Led accounts for 54% and participating for 46% of round participation. All available history
CategoryDeals (count)Share (%)
Led2154%
Participating1846%
Medicxi: Single-lead accounts for 52% and co-led for 48% of lead dynamics.All available history.
Medicxi: Single-lead accounts for 52% and co-led for 48% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1152%
Co-led1048%

Team

David Grainger

Partner

Francesco De Rubertis

Co-Founder & Partner

Giovanni Mariggi
Giovanni Pericolini

Finance Director & CFO

Giuseppe Zocco

Co-Founder & Partner

Kevin Johnson

Co-Founder & Partner

Michele Ollier

Co-Founder & Partner

Nick Williams
Richard Lee

Operating Partner

Trevor Baglin

Venture Partner

Victoria Taylor

Associate